CD8A and neoplasm: Studies have shown that caspase inhibitors modulate radio chemoimmunotherapy-induced cell death in B16 melanoma cells, inducing an anti-tumor immunity in a HMGB1-, nucleotide-, and CD8+ T-cell-dependent manner.